Pilot and Feasibility Program in Human Islet Biology

The summary for the Pilot and Feasibility Program in Human Islet Biology grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Pilot and Feasibility Program in Human Islet Biology: Much of our understanding of the basic biology and function of the beta cell and the pancreatic islet comes from studies of immortalized cell lines and mouse tissue. However, differences in the general structure and organization of mouse and human islets have been identified, and it remains uncertain if these structural differences reflect functional differences as well. With the variable success in islet transplantation and the inability to use in vitro data to reliably predict islet engraftment and function, it is important to learn all that we can about the structure, organization, and signaling properties of human islets, and to compare and contrast these findings with those reported with rodent models of islet function used to date. The information gained from these studies should increase our ability to develop new reagents for use in in vivo imaging studies of the human islet, to develop fingerprinting assays for use in predicting human islet transplant success, and to further develop cellular therapies for potential use in the treatment of type 1 diabetes.
Federal Grant Title: Pilot and Feasibility Program in Human Islet Biology
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-DK-03-021
Type of Funding: Grant
CFDA Numbers: 93.847
CFDA Descriptions: Diabetes, Endocrinology and Metabolism Research
Current Application Deadline: No deadline provided
Original Application Deadline: November 20, 2003 and July 20, 2004
Posted Date: Jul 22, 2003
Creation Date: Aug 19, 2004
Archive Date: Aug 19, 2004
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [email protected] NIH OER Webmaster
Similar Government Grants
Kidney Technology Development Research Education Program (R25 - Independent Clinical Trial...
Adaptation of Diabetes Control Technologies for Older Adults with T1D (R01 Clinical Trial...
Discovery of Early Type 1 Diabetes Disease Processes in the Human Pancreas [HIRN Consortiu...
Diabetes Research Centers (P30 Clinical Trial Optional)
Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogen...
Proteomic and Metabolomic Approaches to Diagnose Diabetes and Pre-Diabetes
Molecular Therapy Core Centers
Diabetes Endocrinology Research Centers
More Grants from the National Institutes of Health
Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...
NIDCR Predoctoral to Postdoctoral Transition Award to Promote a Diverse Dental, Oral and C...
Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed...
Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...
Protective Strategies to Reduce Amyloid Related Imaging Abnormalities (ARIA) After Anti-Am...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com